Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by María Belén Federico
Polo-Like Kinase 1 Inhibition as a Therapeutic Approach to Selectively Target BRCA1-Deficient Cancer Cells by Synthetic Lethality Induction
Clinical Cancer Research
Cancer Research
Oncology
Related publications
Polo-Like Kinase 1 Is a Therapeutic Target in High-Risk Neuroblastoma
Clinical Cancer Research
Cancer Research
Oncology
Modulating Polo-Like Kinase 1 as a Means for Cancer Chemoprevention
Pharmaceutical Research
Organic Chemistry
Biotechnology
Molecular Medicine
Pharmacology
Pharmaceutical Science
Synthetic Lethality as a Targeted Approach to Advanced Prostate Cancer
Polo-Like Kinase 4 Inhibition: A Strategy for Cancer Therapy?
Cancer Cell
Cancer Research
Oncology
Cell Biology
Genetic Depletion of Polo-Like Kinase 1 Leads to Embryonic Lethality Due to Mitotic Aberrancies
BioEssays
Biochemistry
Genetics
Molecular Biology
Polo-Like Kinase-1 as a Novel Target in Neoplastic Mast Cells: Demonstration of Growth-Inhibitory Effects of Small Interfering RNA and the Polo-Like Kinase-1 Targeting Drug BI 2536
Haematologica
Hematology
Downregulation of Human Polo-Like Kinase Activity by Antisense Oligonucleotides Induces Growth Inhibition in Cancer Cells
Oncogene
Cancer Research
Genetics
Molecular Biology
Polo-Like-Kinase 1: A Key Cellular Target for Anti-HBV Therapy?
Hepatology
Medicine
Hepatology
Enabling and Disabling Polo-Like Kinase 1 Inhibition Through Chemical Genetics
ACS Chemical Biology
Biochemistry
Medicine
Molecular Medicine
